SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4

Clinical trial NCT02941328 · COMPLETED

Trial details

NCT number: NCT02941328
Sponsor: UMC Utrecht
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Spinal Muscular Atrophy SMA Kugelberg-Welander Disease

Start date: 2015-12-01
Primary completion: 2018-01-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.